Abstract: Mutations in the NNT gene (nicotinamide nucleotide transhydrogenase), which is involved in NADPH generation in mitochondria, have recently been described in familial glucocorticoid deficiency. We report two patients, one with isolated glucocorticoid deficiency and the other with a combined glucocorticoid and mineralocorticoid deficiency. Through whole exome sequencing, both cases were found to carry two different NNT mutations, confirming previous results for these patients. Each patient also carries multiple heterozygous protein-altering mutations in other genes involved in steroid hormone biogenesis and regulation. The patient with a combined glucocorticoid and mineralocorticoid deficiency is a compound heterozygote for common missense variants in the ME3 gene (mitochondrial malic enzyme 3), the product of which also generates NADPH in mitochondria. Mutations in NNT are the likely proximal cause of the glucocorticoid deficiency in both patients, but genetic background effects may be important in modulating the specific phenotype of adrenal insufficiency.
Introduction
Familial glucocorticoid deficiency (FGD) is an autosomal recessive disorder defined by adrenocorticotropin (ACTH) resistant isolated cortisol deficiency (MIM [202200] ). It can be caused by mutations in the genes MC2R (MIM [607397] ), MRAP (MIM [699196] ) and rarely steroid acute regulatory protein (STAR, MIM [600617] ). 1 Recently, mutations in the genes encoding minichromosome maintenance-deficient 4 (MCM4, MIM [602638] ) and nicotinamide nucleotide transhydrogenase (NNT, MIM [607878] ) have also been reported as causal. [2] [3] [4] [5] NNT is involved in NADPH biosynthesis in mitochondria, and is important to maintain the appropriate oxidoreductive state. [6] [7] [8] [9] Adrenal insufficiency, which lead to both glucocorticoid and mineralocorticoid deficiency, may also be caused by mutations in STAR, or in other genes such as NR5A1 [MIM 184757] or NR0B1 [MIM 300473 ]. Mutations in the latter, however, lead to more severe phenotypes which include defects in sexual development.
Two ACTH-resistant patients with different clinical presentations in one important aspect (isolated glucocorticoid deficiency versus combined gluco-plus mineralocorticoid deficiency) were analyzed by whole exome sequencing after provisional exclusion of causal mutations in MC2R and MRAP. This lead to the identification of compound heterozygous mutations in NNT in both patients. These results confirmed the same mutations, previously reported in these patients. 5 The different presentations of the two patients were not obviously explained by the NNT variants; therefore we looked for additional genetic variants in genes involved in steroid hormone biosynthesis or regulation that might be potential genetic modifiers. Multiple interesting proteincoding variants were identified, although the functional consequences of these will be challenging to validate.
Materials and Methods

Ethics statement
This study was approved by the Ethics Committee of the CHU Sainte-Justine. The parents of the patients gave written informed consent for the genetic analyses.
Laboratory analyses and whole exome sequencing
Genomic DNA from patients and unaffected family members was obtained from venous blood using standard methods. Exome analysis was performed using the Agilent 50Mb SureSelect library of biotinylated RNA oligonucleotides, followed by pairedend 100 nt sequencing on Illumina HiSeq2000. Hybrid capture and next-generation sequencing were performed at the McGill University and Genome Quebec Centre for Innovation. Data were analyzed using NextGene (SoftGenetics, Inc.) as well as separately with a custom pipeline using BWA, Picard, Samtools and Annovar to align reads to the human consensus genome sequence, and identify and annotate variants. 10 The two exome samples generated 10 or 14 gigabases (Gb) of high quality aligned bases, with median 60 or 112-fold coverage respectively of targeted exons after filtering for PCR-generated duplicate reads. More than 90% of CCDS annotated coding region bases were covered by at least 10 independent reads. For primary mutation analysis, variants were filtered using data from the 1000 Genomes project and the NHLBI exome sequencing project. Common variants and potential false positives due to technical artifacts were removed by comparison with a dataset of variants from exomes of other unrelated projects analyzed with the same informatics pipeline. PCR-based Sanger capillary fluorescent sequencing was performed using standard methods, and data were analyzed using MutationSurveyor ( SoftGenetics, Inc.).
Bioinformatics
Potential effects of amino acid substitutions were analyzed using the mutation prediction tools Polyphen2, 11 SIFT, 12 SNPS&GO, 13 and Provean. 14 The NNT gene encodes two annotated mRNAs according to RefSeq, with different first exons but identical coding potential. Mutations in NNT were numbered consistently with the previous report.
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Results
Clinical ascertainment
Over the course of two years, one infant was referred to our service with severe hypoglycemia and another with salt wasting, hyponatremia, and hyperkalemia. Both had elevated serum ACTH, consistent with primary adrenal insufficiency. After stepwise exclusion of the various causes of primary adrenal insufficiency according to our published algorithm, 15 we considered ACTH resistance. However, PCR-based Sanger sequencing of annotated protein coding exons was negative for potential causal mutations in MC2R and MRAP, genes known to cause ACTH resistance when mutated (data not shown). 16 Later, in the course of the present study, these two patients were sequenced in the NNT gene by another team, leading to the identification of mutations in NNT in both children.
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Case 1
A 14 month-old girl, the second child born to nonconsanguineous French-Canadian parents, without any relevant personal or family history, was admitted for severe fasting hypoglycemia (0.7 mmol/L) and metabolic acidosis (pH 7.15; bicarbonates 14.6 mmol/L) but normal serum electrolytes (sodium 139 mmol/L, potassium 5.1 mmol/L) occurring during a febrile episode (40 °C). On admission, weight was 9.4 kg (50th percentile), length 80 cm (85th percentile). Growth had been normal before this episode. Examination noted deeply hyperpigmented skin but was otherwise unremarkable. The external genitalia were normal. Resuscitation including glucose and hydrocortisone led to a fast recovery.
Twenty-four hours after hydrocortisone withdrawal, serum cortisol at 08h00 was undetectable (,11 nmol/L) and did not rise after stimulation with 1 µg of ACTH intravenously. Serum ACTH at 08h00 on the same day was 713 pmol/L (N: 0.33-15.6 pmol/L). Abdominal ultrasound showed that both adrenal glands were calcified. Antibodies to CYP21 were undetectable and there was no evidence in favor of a defect in STAR or in any enzyme involved in glucocorticoid synthesis, adrenoleukodystrophy, or triple-A syndrome.
The patient was diagnosed as having ACTHresistant isolated glucocorticoid deficiency and has been treated with hydrocortisone (10-13 mg/m 2 /d) for the past 6 years. She has normal serum electrolytes and renin, and is growing and developing normally. Currently the patient is 8 years old and has a 14-year old sister, who is healthy with no clinical evidence of adrenal dysfunction.
Case 2
A 13-month-old boy, a first child born to nonconsanguineous French Canadian parents after a normal pregnancy, was admitted for a retro-pharyngeal abscess with thrombosis of the internal jugular vein and compression of the internal carotid artery leading to infarction of the left parietal lobe. On admission, weight was 10.4 kg (25th percentile), length 78 cm (50th percentile). Growth had been normal before this episode. During hospitalization, he was treated with intravenous antibiotics and was tubefed but he nevertheless continued to lose weight, with vomiting and hypotension. Serum sodium and potassium were 126 mmol/L and 8.2 mmol/L, respectively. Simultaneously, urinary sodium was inappropriately high (63 mmol/L) and serum cortisol inappropriately low (30 nmol/L). High serum ACTH (466 pmol/L) and renin (202 ng/L) were consistent with combined gluco-and mineralocorticoid deficiency. The patient promptly recovered under hydrocortisone and fludrocortisone replacement therapy. Ultrasound scan showed normal adrenal glands. Serum 17-OH-Progesterone was normal and anti-CYP21 antibodies were undetectable. There was no clinical argument for triple A syndrome and VLCFA levels were normal, ruling out adrenoleukodystrophy. The DAX1 and SF1 genes, in addition to MC2R and MRAP, were normal by traditional coding exon sequencing. The patient has been maintained on combined hydrocortisone and fludrocortisones. Currently, the patient is 9-years old and has one 2-year old sister, who is healthy with no clinical evidence of adrenal dysfunction.
Exome sequencing and mutation validation
At the time the study was initiated, no etiology had been established for the two patients' adrenal insufficiency, and we therefore commenced exome sequencing to look for causal mutations in potentially novel genes. A recessive mode of inheritance was suggested by the normal status of all four parents, and a founder effect was considered based on the French-Canadian ethnicity of both families. However, considering variants in or near coding regions, no annotated protein-coding gene was found to carry a private shared homozygous pathogenic variant in both patients (simultaneously rare, with minor allele frequency , 0.01 in the 1000 Genomes database, and not seen in other exomes of unrelated samples; potentially protein-altering by nonsynonymous codon change, insertion/ deletion with our without frameshift, gain or loss of stop codon, intronic or exonic consensus splice
Journal of Genomes and Exomes 2013:1 site mutation, or more extended splice site mutation). In patient 1, 7 genes contained either a homozygous or two heterozygous private non-synonymous variants. In patient 2, 23 genes contained either a homozygous or two heterozygous private non-synonymous variants. The only gene from these two lists shared between both patients was NNT, encoding nicotinamide nucleotide transhydrogenase. Patient 1 had two different heterozygous truncating frameshift alleles in NNT (c.63delG, p.S22Pfs*6; c.1864-1G . T, p.I622Dfs*1) (Fig. 1A and Supplementary Fig. S1 ); patient 2 had one heterozygous truncating frameshift allele in NNT (c.1107_1110delTCAC, p.H370*) and one heterozygous missense in NNT (c.3027T . G, p.N1009K) (Fig. 1B and Supplementary Fig. S1 ). Patient 1 was also heterozygous for two missense variants in NNT present in dbSNP (Supplementary Table 2 ).
To verify the mutations found in NNT, and to document inheritance phase, we performed PCR-based Sanger sequencing on DNA from the patients and their parents. In the case of patient 1, the father was heterozygous for mutation c.63delG, p.S22Pfs*6, the mother was heterozygous for mutation c.1864-1G . T, p.I622Dfs*1 and the patient was thus a compound heterozygote (Fig. 1A and data not shown) . The unaffected sister showed no NNT mutations. In the case of patient 2, the father was heterozygous for mutation c.T3027T . G, p.N1009K, but neither parent carried the mutation c.1107_1110delTCAC, p.H370* (Fig. 1B and data not shown) . Therefore this second mutation in the patient presumably arose de novo in a parental germ line, but there is no way to distinguish in which parent. The data are nonetheless consistent with the patient being a compound heterozygote. The unaffected sister showed no NNT mutations.
The mutation p.N1009K is predicted as probably damaging by Polyphen2 both HumDiv (score of 1.000, sensitivity: 0.00; specificity: 1.00) and HumVar (score of 0.989, sensitivity: 0.52; specificity: 0.95), not tolerated by SIFT (threshold 0.05), as deleterious by Provean (score −5.581), and as disease related by SNPs&GO.
In the course of our work, we were informed by Dr. L.A. Metherell that mutations in the gene NNT had been found in previously obtained DNA from our two patients (our family 1 is equivalent to their kindred 12, our family 2 is equivalent to their kindred 9) through candidate gene sequencing based on other results from their cohort. 5 The four NNT mutations reported in that study in our patients are identical to the ones discovered by our whole exome sequence analysis. Importantly, in that study only glucocorticoid deficiency was mentioned as a clinical feature of mutations in NNT; the mineralocorticoid deficiency of our patient 2 was not reported, nor was a full case report of either patient presented. Moreover, segregation of the variants in trans which we have determined, was not assessed in the previous study due to lack of parental or sibling samples.
Additional genetic variants
The significant difference in clinical presentation in the two patients is not obviously explained by the mutations found in NNT; patient 1, who is clinically less severe, has the more severe mutations formally. Therefore, taking advantage of the whole exome variant data on both patients, we looked for additional genetic variants in genes involved in steroid hormone biosynthesis or regulation. We generated a list of 27 such genes (including NNT, Table 1 in Supplementary Data) and filtered all exome variants in the two patients for variants potentially altering protein-coding potential. In looking for potential genetic modifiers, we considered known variants (ie, not private), since such variants might conceivably influence the phenotype in our patients carrying pathogenic mutations in NNT, even if having no phenotypic consequences on their own. Some of the variants called in the exome data were verified by Sanger sequencing (Supplement Table 2 ).
Not surprisingly, both patient exomes contain additional potential variants in relevant pathway genes ( Supplementary Fig. S2 and Supplementary Table 2 ). In particular, patient 2 has two heterozygous variants in the gene ME3 (c.G972C, p.K324N equivalent to dbSNP rs1042780, c.G1252A, p.A418T equivalent to dbSNP rs3182235, Supplementary Fig. S2) ; each parent is singly heterozygous, thus the patient is a compound heterozygote (data not shown). Supplementary Fig. S3) ; presumably the incomplete conservation caused the different prediction tools to yield different interpretations of the variant.
Discussion
In the only paper to date describing patients with NNT mutations (which included our two patients), the phenotype was reported as isolated glucocorticoid deficiency, yet one of our patients had clear evidence of combined gluco-and mineralocorticoid deficiency. Thus our findings expand the genotype-phenotype correlation for NNT, which should be considered as a candidate gene in patients with otherwise unexplained primary adrenal insufficiency. We have also documented that the mutations in NNT are in trans, a point which was left open in the previous report on these patients. 5 The differential diagnosis between isolated glucocorticoid deficiency and combined gluco-and mineralocorticoid deficiencies is not always easy, especially at the time of presentation of an acutely and severely ill infant. This makes it challenging to determine the optimum hormonal treatment regime, since treatment with cortisol replacement alone leaves the patient at potential risk for a severe reaction if isolated glucocorticoid deficiency progresses spontaneously to more severe adrenal insufficiency. In the present study however, the presentation of the two patients was clearly different from an early age.
We sought to explain this phenotypic difference by looking for additional genomic variants in our exome sequence data. Among several additional proteinaltering variants found in relevant genes, compound heterozygous ME3 variants were noted in patient 2. These were of particular interest as malic enzyme 3 also generates mitochondrial NADPH, thus even modest functional variation in this gene might have significant effects in patients sensitized by severe mutations in NNT. Further work will be required to test whether these variants affect ME3 activity.
NADPH metabolism is complex, and proceeds via multiple cytosolic and mitochondrial pathways. In mitochondria, NADPH can be generated through three different reactions: NADP-linked malic enzyme, isocitrate dehydrogenase, and nicotinamide nucleotide transhydrogenase (NNT). 17 These various pathways to NADPH are differentially relevant in various tissue or cell types. NADPH itself functions as a critical cofactor of many enzymatic conversions. Meimaridou et al, in their discussion of the role of NNT in glucocorticoid deficiency, emphasize its function in the regeneration of reduced glutathione. 5 Mice carrying a severe spontaneous allele of NNT (deleted for five coding exons in frame), as well as those with new ENUderived alleles, exhibit increased toxicity due to oxidative stress together with insulin resistance. 18, 19 However, NADPH is a required cofactor for many steroid hormone biosynthetic reactions. Given the multiple potential sources of mitochondrial NADPH, it is difficult to assess how the rates of these various biosynthetic steps might be affected
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In conclusion, our exome sequencing approach identified NNT mutations, which were simultaneously found by a candidate gene approach, in two infants with very low cortisol and high ACTH. It underlines the power of exome sequencing in pediatric endocrinology, as also illustrated by our recent discovery of mutations in POMC leading to bio-inactive ACTH. 20 In the present work, exome sequencing also led to the identification of variants in ME3, a potential disease modifier, in our patient with NNT mutations and additional mineralocorticoid deficiency. 
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